The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Janux Therapeutics Inc shares valued at $100,020 were sold by Meyer Andrew Hollman on Apr 21 ’25. At $30.00 per share, Meyer Andrew Hollman sold 3,334 shares. The insider’s holdings dropped to 82,139 shares worth approximately $2.6 million following the completion of this transaction.
Also, ANDREW MEYER purchased 3,334 shares, netting a total of over 98,986 in proceeds.
Before that, RA CAPITAL MANAGEMENT, L.P. had added 372,093 shares to its account. In a trade valued at $11,453,023, the Director bought Janux Therapeutics Inc shares for $30.78 each. Upon closing the transaction, the insider’s holdings increased to 372,093 shares, worth approximately $317.18 million.
As published in a research note from H.C. Wainwright on December 03, 2024, Janux Therapeutics Inc [JANX] has been retained to a Buy and the price target has been revised to $70. Analysts at BTIG Research resumed the stock at ‘”a Buy”‘ outlook in a report released in early December. As of November 22, 2024, Leerink Partners has initiated its “an Outperform” rating for JANX. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Buy” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a surge of approximately 8.81%. Over the course of the year, Janux Therapeutics Inc shares have dropped approximately -40.94%. Shares of the company reached a 52-week high of $61.59 on 01/07/25 and a 52-week low of $22.52 on 04/09/25. A 50-day SMA is recorded $30.88, while a 200-day SMA reached $43.59.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 30.63, which, if violated, would cause prices to drop to 29.64. In the upper region, resistance lies at 32.60. The next price resistance is at 33.57. RSI (Relative Strength Index) is 58.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.40, which suggests the price will increase in the coming days. Percent R is at 9.59%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
